C3is Completes 28M Unit Public Offering; Aegis Exercises Over-Allotment
Ticker: CISS · Form: 6-K · Filed: Jan 23, 2024 · CIK: 1951067
Complexity: moderate
Sentiment: bearish
Topics: public-offering, share-dilution, warrants, capital-raise
TL;DR
**C3is just flooded the market with 28M new units, expect dilution and potential price drop.**
AI Summary
On January 23, 2024, C3is Inc. completed a public offering of 28,000,000 units, raising capital by selling 6,660,000 common units and 21,340,000 pre-funded units. Each unit included common shares or pre-funded warrants, along with Class B-1 Warrants exercisable at $0.375 and Class B-2 Warrants exercisable at $0.425. Aegis Capital Corp., the underwriter, also partially exercised an over-allotment option for 2,100,000 additional units. This matters to investors because the significant issuance of new shares and warrants could dilute the value of existing shares and potentially depress the stock price due to increased supply.
Why It Matters
This offering significantly increases the number of C3is Inc. shares and warrants in the market, which typically leads to dilution for existing shareholders and can put downward pressure on the stock price.
Risk Assessment
Risk Level: high — The substantial increase in outstanding shares and warrants through this offering presents a high risk of significant share dilution and potential stock price depreciation for current investors.
Analyst Insight
A smart investor would carefully evaluate the potential for significant share dilution and its impact on the stock price before making any investment decisions, potentially waiting for the market to absorb the new supply.
Key Numbers
- 28,000,000 — total units offered (represents the total number of common and pre-funded units sold in the offering)
- 6,660,000 — common units (part of the total units, each consisting of one common share and warrants)
- 21,340,000 — pre-funded units (part of the total units, each consisting of one pre-funded warrant and warrants)
- 2,100,000 — over-allotment units (additional units purchased by Aegis Capital Corp. through partial exercise of their option)
Key Players & Entities
- C3is Inc. (company) — the registrant completing the public offering
- Aegis Capital Corp. (company) — the underwriter of the public offering
- $0.01 (dollar_amount) — par value per common share and exercise price for pre-funded warrants
- $0.375 (dollar_amount) — exercise price for Class B-1 Warrants
- $0.425 (dollar_amount) — exercise price for Class B-2 Warrants
Forward-Looking Statements
- The stock price of C3is Inc. will experience downward pressure due to the significant increase in outstanding shares and warrants. (C3is Inc.) — high confidence, target: Q1 2024
- Existing shareholders of C3is Inc. will experience dilution of their ownership stake. (C3is Inc. shareholders) — high confidence, target: Ongoing
FAQ
What was the total number of units sold in C3is Inc.'s public offering on January 23, 2024?
C3is Inc. sold a total of 28,000,000 units in its public offering on January 23, 2024, consisting of 6,660,000 common units and 21,340,000 pre-funded units.
What were the exercise prices for the Class B-1 and Class B-2 Warrants included in the units?
The Class B-1 Warrants have an exercise price of $0.375 per Common Share, and the Class B-2 Warrants have an exercise price of $0.425 per Common Share.
Which firm acted as the underwriter for this public offering?
Aegis Capital Corp. acted as the underwriter for C3is Inc.'s public offering.
Did the underwriter exercise any over-allotment options, and if so, for how many units?
Yes, Aegis Capital Corp. partially exercised its over-allotment option for 2,100,000 units on January 23, 2024.
What did each Common Unit consist of in this offering?
Each Common Unit consisted of one common share, par value $0.01 per share, one-half of a Class B-1 Warrant to purchase one Common Share, and one Class B-2 Warrant to purchase one Common Share.
Filing Stats: 754 words · 3 min read · ~3 pages · Grade level 9.3 · Accepted 2024-01-23 17:14:56
Key Financial Figures
- $0.01 — nsisting of one common share, par value $0.01 per share, of the Company (Common Share
- $0.375 — ne Common Share at an exercise price of $0.375 per Common Share or pursuant to an alte
- $0.425 — ne Common Share at an exercise price of $0.425 per Common Share, and (b) 21,340,000 pr
- $7.0 million — able by the Company, were approximately $7.0 million. Attached to this report on Form 6-K
- $7.0 Million — 4 titled C3is Inc. Announces Closing of $7.0 Million Upsized Underwritten Public Offering.
- $1.05 — 0 Common Shares at an exercise price of $1.05 per share, Class B-1 Warrants to purcha
- $25.00 — $0.01 per share, liquidation preference $25.00 per share and conversion price of $0.25
- $0 — 25.00 per share and conversion price of $0.25, subject to adjustment. EXHIBIT IN
Filing Documents
- d741891d6k.htm (6-K) — 15KB
- d741891dex11.htm (EX-1.1) — 197KB
- d741891dex41.htm (EX-4.1) — 113KB
- d741891dex42.htm (EX-4.2) — 114KB
- d741891dex43.htm (EX-4.3) — 80KB
- d741891dex991.htm (EX-99.1) — 10KB
- 0001193125-24-013083.txt ( ) — 531KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: January 23, 2024 C3IS INC. By: /s/ Nina Pyndiah Name: Nina Pyndiah Title: Chief Financial Officer